Ovid Therapeutics and Columbia University are Working on a Treatment for KIF1A Associated Neurological Disorder
According to a story from GlobeNewswire, the biopharmaceutical company Ovid Therapeutics Inc. and Columbia University have recently entered a collaborative partnership that will be focused on developing gene-based treatments for…